Derivatives of arylquinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone

Details for Australian Patent Application No. 2007231842 (hide)

Owner Novartis AG

Inventors Renaud, Johanne; Weiler, Sven; Widler, Leo; Gerspacher, Marc; Beerli, Rene; Altmann, Eva

Agent Davies Collison Cave

Pub. Number AU-B-2007231842

Parent 2003296710

Filing date 5 November 2007

Wipo publication date 29 November 2007

Acceptance publication date 14 April 2011

International Classifications

A61P 5/18 (2006.01) Drugs for disorders of the endocrine system

C07C 17/12 (2006.01) Compounds containing carbon and halogens with or without hydrogen

C07C 45/30 (2006.01) Preparation of compounds having CO groups bound only to carbon or hydrogen atoms

C07C 205/37 (2006.01) Compounds containing nitro groups bound to a carbon skeleton

C07C 205/44 (2006.01) Compounds containing nitro groups bound to a carbon skeleton

C07C 205/45 (2006.01) Compounds containing nitro groups bound to a carbon skeleton

C07C 225/22 (2006.01) Compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly-bound oxygen atoms not being part of a CHO group, e.g. amino ketones

C07C 229/18 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07C 255/24 (2006.01) Carboxylic acid nitriles

C07C 255/25 (2006.01) Carboxylic acid nitriles

C07C 317/18 (2006.01) Sulfones

C07C 317/32 (2006.01) Sulfones

C07C 323/25 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

C07D 213/64 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 239/82 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/93 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 317/58 (2006.01) Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

22 November 2007 Complete Application Filed

29 November 2007 Application Open to Public Inspection

  Published as AU-B-2007231842

14 April 2011 Application Accepted

  Published as AU-B-2007231842

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007231843-Tooth Whitening Products

2007231841-Coloring composition for image formation and method for improving ozone resistance of color image